HOUSTON, Oct. 21, 2014 /PRNewswire/ -- Solanbridge
Group Inc (OTC: SLNX) is pleased to announce that its subsidiary
Solanbridge Group Nova Scotia, Inc., has added Ms. Wendy Coffin to its Board of Directors.
She will act as the subsidiary's Medical Director.
Ms. Coffin joined the Board on October
1, 2014. She will provide Solanbridge with invaluable
medical and pharmaceutical experience.
Charles R. Shirley, CEO of
Solanbridge, stated, "We welcome Ms. Wendy
Coffin to Solanbridge. Ms. Coffin will be working with
Solanbridge to develop products in the emerging medical marijuana
market."
About Wendy Coffin
Wendy is a practising Pharmacist and a business owner. She
is president and pharmacist manager of the Dartmouth Gate Pharmacy
in Dartmouth, Nova Scotia.
Wendy serves on the Economic Committee for the Pharmacy
Association of Nova Scotia. On
this committee she deals with economic and business related issues
including government negotiations. She was a participant in the
provincial Minor Ailment Pilot Project, which was used to evaluate
of the provision of minor ailment assessments and prescribing in
the pharmacy setting.
Wendy is also involved with 'The Bloom Program" in alignment
with Nova Scotia's Mental Health
Strategy in which community pharmacies help to improve the quality
of life for people with mental health and addictions.
Wendy brings two important attributes to Solanbridge: knowledge
of both business and healthcare. Wendy earned an undergraduate
degree in Biology from St. Francis Xavier
University in 1996 and in Pharmacy from Dalhousie University in 2001.
About Solanbridge Group Inc
Solanbridge Group Inc, based in Greater Houston, is a diversified holding
company looking to expand into the medical marijuana industry by
developing commercial grower's licenses in Eastern Canadian medical
marijuana jurisdictions, with the partnership of First Nations and
developing CBD-infused products in Colorado and Nevada. Solanbridge is also pursuing
other acquisitions in the growing medical marijuana field and
partnerships with agribusiness entities.
This release includes "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
These statements are based upon the current beliefs and
expectations of Solanbridge's management and are subject to
significant risks and uncertainties. There can be no guarantees
with respect to that the products will prove to be commercially
successful. All forward-looking statements are inherently
uncertain as they are based on current expectations and assumptions
concerning future events or future performance of the company. If
underlying assumptions prove inaccurate or risks or uncertainties
materialize, actual results may differ materially from those set
forth in the forward-looking statements.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/solanbridge-group-inc-announces-addition-of-wendy-coffin-508198927.html
SOURCE Solanbridge Group Inc